Rigetti Computing vs. Quantum Computing: Which Quantum Tech Stock Is a Better Buy in 2026?

The article compares two unprofitable quantum hardware stocks, with Rigetti posting $7.1 million in 2025 revenue and a $216.2 million net loss, while Quantum Computing generated about $682,000 in revenue and a $18.7 million net loss. Rigetti has stronger near-term traction, including Q1 revenue of $4.4 million versus $1.5 million in 2025 and a government contract worth up to $100 million, but both names trade at very high P/S multiples (848x for Rigetti, 530x for QUBT). Overall, the piece is a speculative stock comparison with limited immediate market impact.

Analysis

The market is still treating quantum hardware as a binary “winner-takes-all” story, but the more actionable lens is contract quality and funding runway. Government demand is effectively a capital-allocation subsidy: it de-risks engineering validation, but it also creates a ceiling on near-term upside because the customer is price-insensitive yet procurement-gated. That makes the first-order trade less about technology purity and more about who can convert pilot credibility into recurring non-government revenue before the cash burn forces dilution.

Relative to QUBT, the higher-signal setup is that RGTI has already crossed the threshold where customer concentration matters more than customer discovery. That is a better problem than having very little commercial traction, because the next re-rating catalyst is not just revenue growth but evidence that a few large programs can become a repeatable pipeline. The second-order risk is that any delay in federal budget timing hits both sentiment and working capital simultaneously, which can compress multiples before fundamentals visibly deteriorate.

QUBT’s photonics angle is a plausible longer-duration hedge against superconducting consensus, but the market is likely over-penalizing scale risk and underestimating dilution risk. A small revenue base with fast growth can still be a trap if the growth does not translate into manufacturing leverage; in this sector, every new node of progress tends to require another capital raise. The cleaner trade is to own the company with the better near-term funding visibility and use the weaker name as the high-beta short, rather than trying to pick the long-term architecture winner now.

The contrarian miss is that the real beneficiaries may be the adjacent incumbents, not the pure-plays. Each incremental dollar of quantum spend can flow to compute infrastructure, cloud distribution, and ecosystem validation at firms like IBM and GOOGL, while the pure-play hardware names absorb most of the execution risk. If quantum adoption accelerates, the best risk-adjusted expression may be a basket of enablers plus a small speculative sleeve in the leading hardware name.

Key Decisions for Investors

• Long RGTIW / short QUBT as a 3-6 month relative-value pair: prefer the name with better funding visibility and institutional validation; size small because both remain dilution-prone.
• If forced into a directional long, use RGTIW on pullbacks after contract headlines; target a 2-3x upside / 50% downside profile only if government award conversion is confirmed by follow-on revenue within 1-2 quarters.
• Avoid outright long QUBT until there is evidence of manufacturing or gross-margin inflection; the current setup is a classic 'good story, expensive optionality' risk with elevated dilution over the next 6-12 months.
• Own IBM or GOOGL as the lower-volatility quantum-enablement expressions; these names can benefit from ecosystem spend and credibility transfer without requiring perfect hardware execution.
• For options traders, consider a small RGTIW call spread financed by a QUBT short or put spread into any sector-wide speculative rally; the edge is in relative credibility, not absolute valuation.